Left-right asymmetry in hearing loss following cisplatin therapy in children - The left ear is slightly but significantly more affected

Ear and Hearing

Volumn 29, Issue 6, 2008, Pages 830-837

  Schmidt, Claus Michael ^a   Knief, Arne ^a   Lagosch, Agatha Katharina ^a   Deuster, Dirk ^a   Am Zehnhoff Dinnesen, Antoinette ^a  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; ANTINEOPLASTIC AGENT;

ADOLESCENT; ARTICLE; ASTROCYTOMA; AUDITORY SYSTEM; AUDITORY THRESHOLD; CANCER CHEMOTHERAPY; CHILD; CHILDHOOD CANCER; DISTORTION PRODUCT OTOACOUSTIC EMISSION; EAR; EPENDYMOMA; EVOKED OTOACOUSTIC EMISSION; FEMALE; GERM CELL TUMOR; GLIOBLASTOMA; HEARING LOSS; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDULLOBLASTOMA; NEUROBLASTOMA; NEUROECTODERM TUMOR; OSTEOSARCOMA; OTOTOXICITY; PURE TONE AUDIOMETRY; RETROSPECTIVE STUDY; SEX DIFFERENCE; TREATMENT OUTCOME; BONE TUMOR; BRAIN TUMOR; CEREBELLUM TUMOR; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; HEMISPHERIC DOMINANCE; NEOPLASM; PATHOPHYSIOLOGY; PRESCHOOL CHILD; SPONTANEOUS OTOACOUSTIC EMISSION;

ADOLESCENT; ANTINEOPLASTIC AGENTS; AUDIOMETRY, PURE-TONE; AUDITORY THRESHOLD; BONE NEOPLASMS; BRAIN NEOPLASMS; CEREBELLAR NEOPLASMS; CHILD; CHILD, PRESCHOOL; CISPLATIN; FEMALE; FUNCTIONAL LATERALITY; HEARING LOSS, BILATERAL; HUMANS; MALE; MEDULLOBLASTOMA; NEOPLASMS, GERM CELL AND EMBRYONAL; NEUROBLASTOMA; OSTEOSARCOMA; OTOACOUSTIC EMISSIONS, SPONTANEOUS; RETROSPECTIVE STUDIES;

EID: 60849132496     PISSN: 01960202     EISSN: None     Source Type: Journal    
DOI: 10.1097/AUD.0b013e31818005a4     Document Type: Article

References (45)

1. Attanasio, G., Barbara, M., Buongiorno, G., et al. (1999). Protective effect of the cochlear efferent system during noise exposure. Ann NY Acad Sci, 884, 361-367.
2. Burns, E. M., Hoberg-Arehart, K., & Campbell, S. L. (1992). Prevalence of spontaneous otoacoustic emissions in neonates. J Acoust Soc Am, 91, 1571-1575.
3. Cazals, Y. (2000). Auditory sensori-neural alterations induced by salicylate. Prog Neurobiol, 62, 583-631.
4. Chung, D. Y., Mason, K., Gannon, R. P., et al. (1983). The ear effect as a function of age and hearing loss. J Acoust Soc Am, 73, 1277-1282.
5. Galaburda, A. M., Sanides, F., & Geschwind, N. (1978). Human brain. Cytoarchitectonic left-right asymmetries in the temporal speech region. Arch Neurol, 35, 812-817. (Pubitemid 9021888)
6. Geschwind, N., & Levitsky, W. (1968). Human brain: left-right asymmetries in temporal speech region. Science, 161, 186-187.
7. Henderson, D., Bielefeld, E. C., Harris, K. C., et al. (2006). The role of oxidative stress in noise-induced hearing loss. Ear Hear, 27, 1-19. (Pubitemid 44378662)
8. Kaltenbach, J. A., Rachel, J. D., Mathog, T. A., et al. (2002). Cisplatin-induced hyperactivity in the dorsal cochlear nucleus and its relation to outer hair cell loss: relevance to tinnitus. J Neurophysiol, 88, 699-714.
9. Khalfa, S., & Collet, L. (1996). Functional asymmetry of medial olivocochlear system in humans. Towards a peripheral auditory lateralization. Neuroreport, 7, 993-996. (Pubitemid 26194468)
10. Khalfa, S., Micheyl, C., Pham, E., et al. (2000). Tones disappear faster in the right ear than in the left. Percept Psychophys, 62, 647-655.
11. Khalfa, S., Micheyl, C., Veuillet, E., et al. (1998). Peripheral auditory lateralization assessment using TEOAEs. Hear Res, 121, 29-34. (Pubitemid 28319895)
12. Khalfa, S., Morlet, T., Micheyl, C., et al. (1997). Evidence of peripheral hearing asymmetry in humans: clinical implications. Acta Otolaryngol (Stockh), 117, 192-196. (Pubitemid 27151754)
13. Khalfa, S., Veuillet, E., & Collet, L. (1998). Influence of handedness on peripheral auditory asymmetry. Eur J Neurosc, 10, 2731-2737. (Pubitemid 28362580)
14. Kimura, D. (1961). Some effects of temporal-lobe damage on auditory perception. Can J Psychol, 15, 156-165.
15. Klis, S. F., O'Leary, S. J., Hamers, F. P., et al. (2000). Reversible cisplatin ototoxicity in the albino guinea pig. Neuroreport, 11, 623-626.
16. Knight, K. R., Kraemer, D. R., & Neuwelt, E. A. (2005). Ototoxicity in children receiving platinum chemotherapy: underestimating a commonly occuring toxicity that may influence academic and social development. J Clin Oncol, 23, 8588-8596.
17. Kok, M. R., van Zanten, G. A., & Brocaar, M. P. (1993). Aspects of spontaneous otoacoustic emissions in healthy newborns. Hear Res, 69, 115-123. (Pubitemid 23279601)
18. Kopke, R., Allen, K. A., Henderson, D., et al. (1999). A radical demise. Toxins and trauma share common pathways in hair cell death. Ann NY Acad Sci, 884, 171-191.
19. Lamprecht-Dinnesen, A., Pohl, M., Hartmann, S., et al. (1998). Effects of age, gender and ear side on SOAE parameters in infancy and childhood. Audiol Neurootol, 3, 386-401. (Pubitemid 28438440)
20. Leake, P. A., Kuntz, A. L., Moore, C. M., et al. (1997). Cochlear pathology induced by aminoglycoside ototoxicity during postnatal maturation in cats. Hear Res, 113, 117-132.
21. McFadden, D. (1993). A speculation about the parallel ear asymmetries and sex differences in hearing sensitivity and otoacoustic emissions. Hear Res, 68, 143-151.
22. McFadden, D. (1998). Sex differences in the auditory system. Dev Neuropsychol, 14, 261-298.
23. McFadden, D., & Mishra, R. (1993). On the relation between hearing sensitivity and otoacoustic emissions. Hear Res, 71, 208-213. (Pubitemid 24029867)
24. Meech, R. P., Campbell, K. C., Hughes, L. F., et al. (1998). A semiquantitative analysis of the effects of cisplatin on the rat stria vascularis. Hear Res, 124, 44-59.
25. Moffat, D. A., & Ramsden, R. T. (1977). Profound bilateral sensorineural hearing loss during gentamicin therapy. J Laryngol Otol, 91, 511-516.
26. Molitor, H., Graessle, O. E., Kuna, S., et al. (1947). Some toxicological properties of streptomycin. J Pharmacol Exp Ther, 86, 15.
27. Nagy, J. L., Adelstein, D. J., Newman, C. W., et al. (1999). Cisplatin ototoxicity: the importance of baseline audiometry. Am J Clin Oncol, 22, 305-308.
28. Nakashima, T., Suzuki, T., Morisaki, H., et al. (1991). Blood flow in the cochlea, vestibular apparatus and facial nerve. Acta Otolaryngol, 111, 738-742.
29. Penner, M. J., Glotzbach, L., & Huang, T. (1993). Spontaneous otoacoustic emissions: measurement and data. Hear Res, 68, 229-237. (Pubitemid 23266745)
30. Peters, U., Preisler-Adams, S., Hebeisen, A., et al. (2000). Glutathione S-transferase genetic polymorphisms and individual sensitivity to the ototoxic effect of cisplatin. Anticancer Drugs, 11, 639-643. (Pubitemid 30782289)
31. Pirilä T., Jounio-Ervasti, K., & Sorri, M. (1992). Left-right asymmetries in hearing threshold levels in three age groups of a random population. Audiology, 31, 150-161.
32. Pirilä , T. (1991). Left-right asymmetry in the human response to experimental noise exposure. Acta Otolaryngol (Stockh), 111, 861-866.
33. Prazma, J., Vance, S. G., & Rodgers, G. (1984). Measurement of cochlear blood flow - new technique. Hear Res, 14, 21-28. (Pubitemid 14087430)
34. Ravi, R., Somani, S. M., & Rybak, L. P. (1995). Mechanism of cisplatin ototoxicity: antioxidant defense system, Pharmacol Toxicol, 76, 386-394.
35. Roberts, J., & Ahula, E. M. (1975). Hearing levels of US youths 12-17 years, United States. National Center for Health Statistics, HEW, (Series 11, No. 145). US GPO, Washington D.C: 84pp.
36. Roche, A. F., Siervogel, R. M., Himes, J. H., et al. (1978). Longitudinal study of hearing in children: baseline data concerning auditory thresholds, noise exposure, and biological factors. J Acoust Soc Am, 64, 1593-1611.
37. Rybak, L. P., Withworth, C. A., Mukherjea, D., et al. (2007). Mechanisms of cisplatin-induced ototoxicity and prevention. Hear Res, 226, 157-167.
38. Schmidt, C. M., Bartholomäus, E., Deuster, D., et al. (2007). The "Muenster classification" of high frequency hearing loss following cisplatin chemotherapy. HNO, 55, 299-306.
39. Sluyter, S., Klis S. F. L., de Groot J. C. M. J., et al. (2003). Alterations in the stria vascularis in relation to cisplatin ototoxicity and recovery. Hear Res, 185, 49-56. (Pubitemid 37346392)
40. Stelmachowicz, P. G., Pittman, A. L., Hoover, B. M., et al. (2004). The importance of high-frequency audibility in the speech and language development of children with hearing loss. Arch Otolaryngol Head Neck Surg, 130, 556-562.
41. Tadros, S. F., Frisina, S. T., Mapes, F., et al. (2005). Loss of peripheral right-ear advantage in age-related hearing loss. Audiolol Neurootol, 10, 44-52. (Pubitemid 40069614)
42. Tsukasaki, N., Whitworth, C. A., & Rybak, L. P. (2000). Acute changes in cochlear potentials due to cisplatin. Hear Res, 149, 189-198. (Pubitemid 30734438)
43. Van Ruijven, M. W. M., de Groot J. C. M. J., Klis, S. F. L., et al. (2005). Cochlear targets of cisplatin: an electrophysiological and morphological time-sequence study. Hear Res, 205, 241-248.
44. Van Zeijl L. G. P. M., Conijn E. A. J. G., Rodenburg, M., et al. (1984). Analyses of hearing loss due to cis-diamminedichloroplatinum- II. Arch Otorhinolaryngol, 239, 255-262. (Pubitemid 14160977)
45. Waters, G. S., Ahmad, M., & Katsarkas, A. (1991). Ototoxicity due to cis-diamminedichloroplatinum in the treatment of ovarian cancer. Influence of dosage and schedule of administration. Ear Hear, 12, 91-102.